Dr. Debashish Chowdhury chairs this insightful keynote session featuring Dr. Subhash Kaul. The discussion critically examines the limitations of traditional acute therapies, including medication overuse, triptan resistance, and persistent unmet clinical needs, setting the stage for a paradigm shift in migraine management.

Why Conventional Acute Migraine Therapies Fall Short: Medication Overuse, Triptan Resistance, and Unmet Clinical Needs

RCP Migraine 2.0: Review of Current Practice in Migraine is a focused one-day virtual academic initiative dedicated to advancing contemporary migraine care through evidence-based discussions and real-world clinical insights. Scheduled for September 11th, 2026, this high-impact program brings together leading experts to address critical gaps in acute migraine management and explore emerging therapeutic paradigms.

Under the scientific leadership of Dr. Debashish Chowdhury, the conference will center on the evolving role of novel therapies, with a special focus on CGRP antagonists such as rimegepant, and their application in routine clinical practice.

The agenda is designed to deliver clinically relevant, practice-oriented insights, covering:
- Limitations of Conventional Therapies – Understanding medication overuse, triptan resistance, and unmet patient needs
- Expanding Acute Treatment Options – Managing the triptan-insufficient response with newer agents like gepants
- Limitations of Conventional Therapies – Understanding medication overuse, triptan resistance, and unmet patient needs - Expanding Acute Treatment Options – Managing the triptan-insufficient response with newer agents like gepants
- Burden of Migraine & Emerging Evidence – Clinical and patient-centric rationale for next-generation therapies - CGRP antagonists in Prophylaxis – Addressing breakthrough attacks and redefining preventive strategies
- Complex Case Discussions – Real-world approaches in migraine prophylaxis with newer agents and status migrainosus with evolving emergency care protocols

Through expert-led keynotes and case-based discussions, RCP Migraine 2.0 aims to bridge the gap between clinical evidence and real-world practice, enabling clinicians to make informed, patient-centric treatment decisions.

Join us for an engaging academic experience and stay at the forefront of innovation in migraine management.

RCP Migraine 2026

This session provides a practical, up-to-date overview of acute ischemic stroke, focusing on early recognition, rapid diagnosis, and time-critical management. Experts will discuss thrombolysis, thrombectomy, patient selection, and real-world challenges, along with post-acute care and secondary prevention. An essential learning opportunity to strengthen decision-making in the golden hour and improve functional outcomes.

Acute Ischemic Stroke

Senior Consultant, Department of Neurology, Krishna Institute of Medical Sciences, Hyderabad

An interactive, case-based discussion exploring challenging thrombolysis decisions in acute ischemic stroke. Through real-world clinical scenarios involving stroke mimics, recent DOAC exposure, recent STEMI, recent ischemic stroke, and extensive early ischemic changes on CT, the session will examine how clinicians approach complex treatment decisions.

Participants will anonymously vote on their preferred management approach before the evidence and guideline recommendations are revealed, followed by a discussion on individualized benefit–risk assessment and how contempor

Dr. Subhash Kaul

4

2k

59k

4.8

Upcoming Sessions

Sessions Taken

588

4.8

552

4.8

1.6k

4.8